Acthar Injection
FDA Label NDC 63004-8710

49 label sections · Submitted to the FDA by Keenova Ard Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Keenova Ard Llc for the product Acthar (NDC 63004-8710). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 infantile spasms, 1.2 multiple sclerosis, 1.3 rheumatic disorders, 1.4 collagen diseases, 1.5 dermatologic diseases, 1.6 allergic states, 1.7 ophthalmic diseases, 1.8 respiratory diseases, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.